Analogues of VIP, helodermin, and PACAP discriminate between rat and human VIP1 and VIP2 receptors

Annals of the New York Academy of Sciences

Volumn 865, Issue , 1998, Pages 247-252

  Gourlet, P ^a   Vandermeers, A ^a   Van Rampelbergh, J ^a   De Neef, P ^a   Cnudd, J ^a   Waelbroeck, M ^a   Robberecht, P ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE RELEASING FACTOR; HELODERMIN; HELOSPECTIN; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; RECEPTOR SUBTYPE; RECOMBINANT PROTEIN; SECRETIN; VASOACTIVE INTESTINAL POLYPEPTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR;

ANIMAL CELL; CARBOXY TERMINAL SEQUENCE; CONFERENCE PAPER; HUMAN; NONHUMAN; RAT; RECEPTOR AFFINITY; SPECIES DIFFERENCE; STRUCTURE ACTIVITY RELATION;

ANIMALIA; PROSPECT HILL VIRUS;

EID: 0032418415     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1998.tb11184.x     Document Type: Conference Paper

References (29)

1. Ishihara, T., R. Shigemoto, K. Mori, K. Takahashi & S. Nagata. 1992. Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide. Neuron 8: 811-819.
2. Couvineau, A., C. Rouyer-Fessard, D. Darmoul, J.-J. Maoret, I. Carrero, E. Ogier-Denis & M. Laburthe. 1994. Human intestinal VIP receptor: Cloning and functional expression of two cDNA encoding proteins with different N-terminal domains. Biochem. Biophys. Res. Commun. 200: 769-776.
3. 2 receptor: molecular characterisation of a cDNA encoding a novel receptor for vasoactive intestinal peptide. FEBS Lett. 334: 3-8.
4. Inagaki, N., H. Yoshida, M. Mizuta, N. Mizuno, Y. Fujii, T. Gonoi, J.-I. Miyazaki & S. Seino. 1994. Cloning and functional characterization of a third pituitary adenylate cyclase-activating polypeptide receptor subtype expressed in insulin-secreting cells. Proc. Natl. Acad. Sci. USA 91: 2679-2683.
5. Svoboda, M., M. Tastenoy, J. Van Rampelberch, J.-F. Goossens, P. De Neef, M. Waelbroeck & P. Robberecht. 1994. Molecular cloning and functional characterization of a human VIP receptor from SUP-T1 lymphoblasts, Biochem. Biophys. Res. Commun. 205: 1617-1624.
6. Ishihara, T., S. Nakamura, Y. Kaziro, T. Takahashi, K. Takahashi & S. Nagata. 1991. Molecular cloning and expression of a cDNA encoding the secretin receptor. EMBO J. 10: 1635-1641.
7. Pisegna, J. R. & S. A. Wank. 1993. Molecular cloning and functional expression of the pituitary adenylate cyclase-activating polypeptide type I receptor. Proc. Natl. Acad. Sci. USA 90: 6345-6349.
8. Svoboda, M., E. Ciccarelli, M. Tastenoy, P. Robberecht & J. Christophe. 1993. A cDNA construct allowing the expression of rat hepatic glucagon receptors. Biochem. Biophys. Res. Commun. 192: 135-142.
9. Thorens, B. 1992. Expression cloning of the pancreatic β cell receptor for the gluco-incretin hormone glucagon-like peptide 1. Proc. Natl. Acad. Sci. USA 89: 8641-8645.
10. Usdin, T. B., E. Mezey, D. C. Button, M. J. Brownstein & T. I. Bonner. 1993. Gastric inhibitory polypeptide receptor, a member of the secretin-vasoactive intestinal peptide receptor family, is widely distributed in peripheral organs and the brain. Endocrinology 133: 2861-2870.
11. Mayo, K. E. 1992. Molecular cloning and expression for pituitary-specific receptor for growth hormone-releasing hormone. Mol. Endocrinol. 6: 1737-1744.
12. Chalmers, D. T., T. W. Lovenberg, D. E. Grigoriadis, D. P. Behan & E. B. De Souza. 1996. Corticotrophin-releasing factor receptors: from molecular biology to drug design. Trends Pharmacol. Sci. 17: 166-172.
13. Jüppner, H., A.-B. Abou-Samra, M. Freeman, X. F. Kong, E. Schipani, J. Richards, L. F. Kolakowski Jr., J. Hock, J. T. Potts Jr., H. M. Kronenberg & G. V. Secre. 1991. A G protein linked receptor for parathyroid hormone and parathyroid hormone-related peptide. Science 254: 1024-1026.
14. Lin, H. Y., T. L. Harris, M. S. Flannery, A. Aruffo, E. H. Kaji, A. Gorn, L. F. Kolakowski Jr., H. F. Lodish & S. R. Goldring. 1991. Expression cloning of an adenylate cyclase-coupled calcitonin receptor. Science 254: 1022-1024.
15. Laburthe, M., A. Couvineau, C. Rouyer-Fessard & L. Moroder. 1985. Interaction of PHM, PHI and 24-glutamine PHI with human VIP receptors from colonic epithelium: comparison with rat intestinal receptors. Life Sci. 36: 991-995.
16. 1 hGRF is a competitive VIP antagonist in the rat. Mol. Pharmacol. 29: 23-27.
17. 1 lymphoma cells: Evidence for receptor glycosylation. J. Receptor Res. 11: 831-848.
18. Gourlet, P., P. De Neef, M.-C. Woussen-Colle, A. Vandermeers, M.-C. Vandermeers-Piret, P. Robberecht & J. Christophe. 1991. The activation of adenylate cyclase by pituitary adenylate cyclase activating polypeptide (PACAP) via helodermin-preferring VIP receptors in human SUP-T1 lymphoblastic membranes. Biochim. Biophys. Acta 1066: 245-251.
19. Ciccarelli, E., J.-P. Vilardaga, P. De Neef, E. Di Paolo, M. Waelbroeck, A. Bollen & P. Robberecht. 1994. Properties of the VIP-PACAP type II receptor stably expressed in CHO cells. Regul. Pept. 54: 397-407.
20. 1, receptor in clonal Chinese hamster ovary cells: pharmacological, functional and molecular properties. Eur. J. Pharmacol. 302: 207-214.
21. Usdin, T. B., T. I. Bonner & E. Mezey. 1994. Two receptors for vasoactive intestinal polypeptide with similar specificity and complementary distributions. Endocrinology 135: 2662-2680.
22. Vertongen, P., S. N. Schiffmann, P. Gourlet & P. Robberecht. 1997. Autoradiographic visualization of the receptor subclasses for Vasoactive Intestinal Polypeptide (VIP) in rat brain. Peptides. 18: 1547-1554.
23. Gourlet, P., P. Vertongen, A. Vandermeers, M.-C. Vandermeers-Piret, J. Rathe, P. De Neef & P. Robberecht. 1997. The long-acting vasoactive intestinal polypeptide agonist RO 25-1553 is highly selective of the VIP, receptor subclass. Peptides 18: 403-408.
24. Robberecht, P., P. Gourlet, P. De Neef, M.-C. Woussen-Colle, M.-C. Vandermeers-Piret, A. Vandermeers & J. Christophe. 1992. Receptor occupancy and adenylate cyclase activation in AR 4-2J rat pancreatic acinar cell membranes by analogs of Pituitary Adenylate Cyclase-Activating Peptides amino-terminally shortened or modified at position 1,2,3,20, or 21. Mol. Pharmacol. 42: 347-355.
25. Couvineau, A., C. Rouyer-Fessard, J.-J. Maoret, P. Gaudin, P. Nicole & M. Laburthe. 1996. Vasoactive intestinal peptide (VIP), receptor. Three nonadjacent amino acids are responsible for species selectivity with respect to recognition of peptide histidine isoleucineamide. J. Biol. Chem. 271: 12795-12800.
26. Vandermeers, A., P. Gourlet, M.-C. Vandermeers-Piret, A. Cauvin, P. De Neef, J. Rathe, M. Svoboda, P. Robberecht & J. Christophe. 1987. Chemical, immunological and biological properties of peptides like vasoactive- intestinal-peptide and peptide-histidine-isoleucinamide extracted from the venom of two lizards (Heloderma horridum and Heloderma suspectum). Eur. J. Biochem. 164: 321-327.
27. Foda, H. D. & S. I. Said. 1989. Helodermin, a C-terminally extended VIP like peptide, evokes long-lasting relaxation. Biomed. Res. 10: 107-110.
28. Turner, J. T., S. B. Jones & D. B. Bylund. 1986. A fragment of vasoactive intestinal peptide, VIP(10-28), is an antagonist of VIP in the colon carcinoma cell line, HT 29. Peptides 7: 849-854.
29. Theriault, Y., Y. Boulanger & S. St-Pierre. 1991. Structural determination of the vasoactive intestinal peptide by two-dimensional H-NMR spectroscopy. Biopolymers 31: 459-464.